José M. Aguado is Professor of Medicine at the Universidad Complutense de Madrid and Head of the Infectious Diseases Unit of the Hospital Universitario 12 de Octubre in Madrid. Completed their training at the Institute of Transplantation, University of Pittsburgh, Pennsylvania, USA. He is past-Chairman of the Study Group of Infection in Compromised Patients (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Coordinator of the Program of Transplant Infections of the National Network of Infectious Diseases (REIPI). Assistant Editor of Transplant Infectious Diseases. He has published over 370 articles, most of them related to the infection in transplant recipeints and other immunocompromised patients.

Robin Avery is currently Professor of Medicine in the Division of Infectious Diseases at Johns Hopkins. She is a graduate of Harvard Medical School and completed her internship, residency, and ID fellowship at Massachusetts General Hospital. She has been an attending physician in the field of Transplant Infectious Disease for 23 years: at Cleveland Clinic from 1993-2012 and at Johns Hopkins from 2012 to the present. She has served as the first Section Head for Transplant ID at Cleveland Clinic and Program Director for the Cleveland Clinic Transplant ID Fellowship; is a past chair of the Infectious Disease Community of Practice of the American Society of Transplantation (AST), and was co-editor of the 1st edition of the AST ID Guidelines. She has co-authored curricula for Transplant Infectious Disease Fellowship and has served on multiple guidelines and consensus panels for the AST, ISHLT, and IDSA. Her research has focused on translational virology in transplantation, viral effects on allograft function, novel therapies for CMV, post-transplant hypogammaglobulinemia, fungal infections, strategies for safer living, and education of patients and clinicians. She has long admired the ICHS and its members for their outstanding dedication to the most pressing questions facing our immunocompromised patients, and for their work in promoting international cooperation and collaboration.

La licenciada Carolina Giuffré es Enfermera especialista en Control de Infecciones recertificada (RECI) por ADECI. Coordinadora de las enfermeras en control de infecciones del Hospital Britanico de Buenos Aires. Asesora experta de la Unidad Global de Prevencion y Control de Infecciones de la OMS y de OPS. Ex presidenta de la Asociación Argentina de Enfermeros en Control de Infecciones (ADECI) y ex miembro del Board de la International Federation of Infection Control (IFIC). Participó en decenas de cursos y congresos en calidad de docente y disertante. Autora de numerosos trabajos científicos en la especialidad, coinvestigadora en diversos estudios multicéntricos y coautora del libros de la especialidad.

Hans H. Hirsch studied medicine at the Albert-Ludwigs-University in Freiburg (Germany) and biochemistry at Oregon State University (OR, USA). He then specialized in internal medicine, infectious diseases and medical microbiology at the University of Basel and the University Hospital Basel. In 2004, the Medical Faculty of the University of Basel appointed him as tenure track Professor for Medical Microbiology (Virology) with promotion to full professor in 2017. Currently, Dr. Hirsch is director of the Clinical Virology providing diagnostic services and he holds a senior clinical appointment as consultant in infectious diseases at the University Hospital Basel. Dr. Hirsch has (co-)authored more than 200 peer-reviewed papers and has been invited to relevant international conferences and guidelines in virology, infectious diseases, and transplantation.

Dr. Michael Ison completed his Internal Medicine Residency and General Internal Medicine Fellowship at Oregon Health Sciences University in Portland, Oregon. He then obtained his Master of Science in Health Evaluation Sciences and did his Infectious Diseases Fellowship at the University of Virginia. He undertook additional training in Transplant Infectious Diseases at the Massachusetts General Hospital and Harvard Medical School under the mentorship of Dr. Jay A. Fishman. He then joined the faculty of the Divisions of Infectious Diseases and Organ Transplantation at Northwestern University Feinberg School of Medicine in 2005. He is currently the Medical Director of the Transplant & Immunocompromised Host Infectious Diseases Service, Northwestern University Comprehensive Transplant Center and Professor of Medicine and Surgery.

He has trained in the Children´s Hospital in Würzburg, Germany, and at the Pediatric Oncology Branch of the National Cancer Institute, Bethesda, USA. His clinical and laboratory research focuses on infectious complications in children with cancer, the development of immunotherapeutic strategies against invasive fungal infections in hematopoietic stem cell transplant recipients, and the interaction of host immune cells and fungi. Dr. Lehrnbecher has published his work in Clinical Infectious Diseases, Journal of Infectious Diseases, Blood, Journal of Clinical Oncology and The Lancet Oncology. He currently chairs the sections “Infection in the immunocompromised child” of the German Society of Pediatric Infectious Diseases and “Infections in Hematology and Oncology” of the Paul-Ehrlich-Gesellschaft and is a co-chair of the supportive care working group of the International Society of Pediatric Oncology.

Dr. Ostrosky-Zeichner is a professor of medicine and epidemiology, the vice-chair of Medicine for Healthcare Quality, the director of the Laboratory of Mycology Research, and the Division Chief at the Division of Infectious Diseases of the McGovern Medical School. He also serves as medical director for epidemiology and stewardship for Memorial Hermann Hospital Texas Medical Center. He has consulted for the FDA and the CDC. He has published over 170 peer-reviewed articles and actively pursues translational and clinical research in medical mycology and hospital epidemiology. His areas of expertise include antifungal susceptibility testing, sero-diagnostics, PK/PD of antifungals, in vivo models of human mycoses, immunology, and clinical trials in prophylaxis and treatment of fungal infections, transplant infectious diseases, as well as hospital epidemiology, antimicrobial stewardship, and infection control.

Steven A. Pergam, MD, MPH is an Associate Member in both the Clinical Research Division and the Vaccine and Infectious Disease Division of the Fred Hutchinson Cancer Research Center, Seattle, WA, USA. He is also an Associate Professor in the Department of Medicine, Division of Allergy and Infectious Diseases, at the University of Washington and an adjunct Associate Professor in the Department of Epidemiology, School of Public Health at the University of Washington. He serves as the Medical Director of Infection Prevention and is an attending physician at the Seattle Cancer Care Alliance. Dr. Pergam focuses his research on the prevention and treatment of infections among immunocompromised patients and has expertise in infection prevention and hospital epidemiology among cancer and transplant patients. He has lectured, published, and mentored students on the prevalence and diagnosis of major viral, fungal and bacterial infections in this population. He serves on numerous national committees including the CDC’s Advisory Committee on Immunization Practices, the American Society of Blood and Marrow Transplant’s Transplant Infectious Diseases Special Interest Group and the National Comprehensive Cancer Network Committee on the Prevention and Treatment of Infections in Cancer, and the National Academy of Sciences Committee on the Management of Legionella in Water Systems. He is an associate editor of Current Opinions in Infectious Diseases and BMC Infectious Diseases, and plays an active role in Transplant Infectious Diseases/Infection Prevention social media through Twitter. In 2014, he was elected to be a fellow of the Infectious Disease Society of America. He received his B.A. from Dartmouth College, his M.D. from the University of Nebraska, his infectious diseases fellowship training at the University of Washington, and his M.P.H. from the University of Washington, School of Public Health.